doxorubicin hydrochloride

Generic: doxorubicin hydrochloride

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxorubicin hydrochloride
Generic Name doxorubicin hydrochloride
Labeler sagent pharmaceuticals
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

doxorubicin hydrochloride 2 mg/mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-207
Product ID 25021-207_f327fef8-8ebd-45a2-a339-72e702c4f8b5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209825
Listing Expiration 2026-12-31
Marketing Start 2013-10-31

Pharmacologic Class

Classes
anthracycline topoisomerase inhibitor [epc] anthracyclines [cs] topoisomerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021207
Hyphenated Format 25021-207

Supplemental Identifiers

RxCUI
1191138 1790100
UNII
82F2G7BL4E

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxorubicin hydrochloride (source: ndc)
Generic Name doxorubicin hydrochloride (source: ndc)
Application Number ANDA209825 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (25021-207-25) / 25 mL in 1 VIAL
  • 1 VIAL in 1 CARTON (25021-207-51) / 100 mL in 1 VIAL
source: ndc

Packages (2)

25021-207-25 1 VIAL in 1 CARTON (25021-207-25) / 25 mL in 1 VIAL 25021-207-51 1 VIAL in 1 CARTON (25021-207-51) / 100 mL in 1 VIAL

Ingredients (1)

doxorubicin hydrochloride (2 mg/mL)

Linked Drug Pages (1)

doxorubicin hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f327fef8-8ebd-45a2-a339-72e702c4f8b5", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1191138", "1790100"], "spl_set_id": ["ae80bd3a-b99a-4e01-a444-b9d05687f00e"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-207-25)  / 25 mL in 1 VIAL", "package_ndc": "25021-207-25", "marketing_start_date": "20131031"}, {"sample": false, "description": "1 VIAL in 1 CARTON (25021-207-51)  / 100 mL in 1 VIAL", "package_ndc": "25021-207-51", "marketing_start_date": "20131031"}], "brand_name": "doxorubicin hydrochloride", "product_id": "25021-207_f327fef8-8ebd-45a2-a339-72e702c4f8b5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "25021-207", "generic_name": "doxorubicin hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "doxorubicin hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209825", "marketing_category": "ANDA", "marketing_start_date": "20131031", "listing_expiration_date": "20261231"}